Shionogi & Co Ltd (4507) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +0,99%	1 093,81	+10,77	+0,99%	—	1 083,04	1 082,63	1 099,01	1 080,59	—	—
SIXC Communications SIXC Communications	SIXC +1,06%	608,77	+6,39	+1,06%	—	602,38	602,38	609,75	599,75	—	—
SIXE Energy SIXE Energy	SIXE +0,96%	1 254,81	+11,98	+0,96%	—	1 242,83	1 229,31	1 258,88	1 220,51	—	—
SIXI Industrials SIXI Industrials	SIXI +2,76%	1 761,11	+47,29	+2,76%	—	1 713,82	1 715,47	1 763,11	1 715,47	—	—
SIXM Financials SIXM Financials	SIXM +0,40%	642,58	+2,59	+0,40%	—	639,99	636,98	644,04	631,81	—	—
SIXR Staples SIXR Staples	SIXR +1,63%	851,13	+13,67	+1,63%	—	837,46	840,30	852,55	840,30	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,76%	217,98	+3,76	+1,76%	—	214,22	214,22	218,25	214,05	—	—
SIXT Technology SIXT Technology	SIXT +0,23%	3 211,83	+7,45	+0,23%	—	3 204,38	3 215,04	3 217,44	3 159,90	—	—
SIXU Utilities SIXU Utilities	SIXU +2,55%	948,98	+23,60	+2,55%	—	925,38	927,91	949,76	927,91	—	—
SIXV Health care SIXV Health care	SIXV +2,20%	1 474,52	+31,81	+2,20%	—	1 442,71	1 443,01	1 477,90	1 443,01	—	—
SIXY Discretionary SIXY Discretionary	SIXY +1,30%	2 392,12	+30,78	+1,30%	—	2 361,34	2 391,00	2 399,18	2 354,52	—	—

4507:TYO

Shionogi & Co Ltd

3 170,00 JPY

−0,31%

(−10,00) 1 D

30. apr., 15:30:00 GMT+9 · JPY

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for 4507 …

Åpne

3 157 JPY

Høy

3 175 JPY

Lav

3 102 JPY

Markedsverdi

2,82 bill.

Snittvolum

2,74 mill.

Volum

4,78 mill.

Utbytte

2,08 %

Kvartalsvis utbytte

16 JPY

Første dato etter utbytte

29. sep. 2025

P/E-forhold

13,85

52 u høy

3 758 JPY

52 u lav

2 162 JPY

EPS

229 JPY

Utestående aksjer

314,50 mill.

Antall ansatte

Relaterte aksjer

4502

Takeda Pharmaceutical Company

5 270,00 JPY

−0,36%

4506

Sumitomo Pharma Co Ltd

1 719,50 JPY

−7,10%

4568

Daiichi Sankyo Co Ltd

2 588,50 JPY

−2,34%

5401

Nippon Steel & Sumitomo Metal Corporation

572,30 JPY

−0,95%

Nyhetssaker

Fra kilder på nettet

Stock Titan

for 10 minutter siden

Tariffs cut Euro Tech sales to China, pushing 2025 revenue down 13.8%

Simply Wall Street

for 14 minutter siden

FTAI Aviation (FTAI) Net Margin Breakout Reinforces Bullish Earnings Narrative

Simply Wall Street

for 23 minutter siden

Acadia Healthcare (ACHC) Returns To Q1 Profit Challenging Deep-Loss Bear Narratives

Reuters

for 23 minutter siden

S&P Dow Jones Indices considers new index rules as mega IPOs loom

Profil

Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana. Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines. In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan. Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV. The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index. In June 2023, Shionogi announced its acquisition of Qpex Biopharma for approximately $140m. Wikipedia

Om Shionogi & Co Ltd

Administrerende direktørIsao Teshirogi

Ansatte4,96k

Grunnlagt1878

HovedkontorOsaka, Osaka, Japan

Sektor-

Nettstedshionogi.com

Alle verdier i JPY	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	104,67 mrd.	99,78 mrd.	113,18 mrd.	147,72 mrd.
Varekostnad	17,79 mrd.	12,32 mrd.	16,94 mrd.	25,09 mrd.
Direkte driftskostnader	17,79 mrd.	12,32 mrd.	16,94 mrd.	25,09 mrd.
Utgifter til forskning og utvikling	29,16 mrd.	24,89 mrd.	27,55 mrd.	29,87 mrd.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	23,87 mrd.	25,82 mrd.	27,56 mrd.	35,27 mrd.
Driftskostnader	56,78 mrd.	52,37 mrd.	56,57 mrd.	48,45 mrd.
Totale driftskostnader	74,57 mrd.	64,68 mrd.	73,51 mrd.	73,54 mrd.
Driftsinntekter	30,10 mrd.	35,10 mrd.	39,67 mrd.	74,18 mrd.
Andre ikke-operasjonelle inntekter	−1,14 mrd.	−1,00 mill.	-	−1,00 mill.
EBT inkludert uvanlige elementer	44,87 mrd.	46,33 mrd.	52,06 mrd.	92,89 mrd.
EBT uten uvanlige elementer	53,35 mrd.	46,33 mrd.	52,06 mrd.	93,10 mrd.
Kostnad for inntektsskatt	8,68 mrd.	6,98 mrd.	7,87 mrd.	18,21 mrd.
Faktisk avgiftssats	19,33 %	15,07 %	15,12 %	19,60 %
Andre driftskostnader	−2,00 mrd.	1,17 mrd.	979,00 mill.	−17,25 mrd.
Nettoinntekt	36,63 mrd.	39,36 mrd.	44,19 mrd.	74,68 mrd.
Netto fortjenestemargin	35,00 %	39,44 %	39,04 %	50,56 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	25,40 mrd.	13,56 mrd.	14,21 mrd.	20,53 mrd.
Rentekostnader	-	−2,33 mrd.	−1,82 mrd.	−1,61 mrd.
Netto rentekostnader	25,40 mrd.	11,23 mrd.	12,38 mrd.	18,92 mrd.
Avskrivnings- og amortiseringskostnader	−3,26 mrd.	-	−485,00 mill.	-
EBITDA	35,30 mrd.	40,11 mrd.	44,83 mrd.	80,21 mrd.
Gevinst eller tap ved salg av eiendeler	254,00 mill.	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning